FDA Inspection 1305074 — The American National Red Cross

The American National Red Cross — FEI 3002353304

The FDA completed an inspection of The American National Red Cross on February 24, 2026 in San Diego, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 24, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Blood and Blood Products
Location
San Diego, CA (United States)